Results 121 to 130 of about 5,578,781 (262)

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Digital health technology companies' experiences of the Finnish Digi-HTA method: An interview study

open access: yesFinnish Journal of eHealth and eWelfare
Health Technology Assessment (HTA) is becoming a core activity for digital health technology companies. Engaging with HTA at the earliest possible stage is beneficial for companies in the development of solutions and in optimizing and prioritizing their
Petra Kämäräinen, Heidi Hintsala
doaj   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Inequality Matters

open access: yesEuropean Journal of Health Communication (EJHC)
The use of digital health technologies could offer promising ways for sustainable health opportunities. However, the accessibility and use of such technologies differs between groups in society.
Joyce Bierbooms   +3 more
doaj   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

TRAINING ON USE OF USER-FRIENDLY R-SHINY PROGRAM FOR DETERMINING NUTRITIONAL STATUS OF TODDLERS AT POSYANDU IN THE WORKING AREA OF THE SOBO BANYUWANGI COMMUNITY HEALTH CENTER

open access: yesJurnal Layanan Masyarakat (Journal of Public Services)
Stunting is a form of malnutrition that serves as an important indicator for monitoring the growth and development of toddlers. However, assessing the nutritional status of toddlers does not stop at stunting, but includes a comprehensive understanding of
Nur Chamidah   +5 more
doaj   +1 more source

EVALUATING TELEMEDICINE IN RURAL SETTINGS: ISSUES AND APPLICATIONS [PDF]

open access: yes
Changes in health care policies, demographics, and technology have presented new opportunities for the delivery of medical care services and information to rural communities.
Capalbo, Susan M., Heggem, Christine N.
core   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

open access: yesMolecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley   +5 more
wiley   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy